Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-017961
Filing Date
2018-06-25
Accepted
2018-06-25 18:13:47
Documents
1
Period of Report
2018-06-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4024
  Complete submission text file 0000899243-18-017961.txt   5372
Mailing Address 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address 281 ALBANY STREET CAMBRIDGE MA 02139 617-995-0900
AILERON THERAPEUTICS INC (Issuer) CIK: 0001420565 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AILERON THERAPEUTICS, INC. 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address
Winder Caleb Maxfield (Reporting) CIK: 0001709840 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38130 | Film No.: 18917893